AiCuris and Hybridize Therapeutics enter worldwide license agreement of up to €100M for a…
AiCuris Anti-infective Cures AG (AiCuris), a leading company in the discovery and development of drugs against infectious diseases, and Hybridize Therapeutics (Hybridize), focused on…
Read More...
Read More...
